USA Dermatomycoses Drug Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Dermatomycoses Drug market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Dermatomycoses Drug market. Detailed analysis of key players, along with key growth strategies adopted by Dermatomycoses Drug industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Novan Inc

    • Viamet Pharmaceuticals Inc

    • Dermala Inc

    • Helix BioMedix Inc

    • Sol-Gel Technologies Ltd

    • TGV-Laboratories

    • Blueberry Therapeutics Ltd

    • Vyome Biosciences Pvt Ltd

    • Anacor Pharmaceuticals Inc

    • Daewoong Pharmaceutical Co Ltd

    • Biolab Farmaceutica Ltda

    By Type:

    • BB-2603

    • Clotrimazole

    • Dapaconazole

    • Others

    By End-User:

    • Hospital

    • Clinic

    • Others

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Dermatomycoses Drug Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Dermatomycoses Drug Market Size and Growth Rate of BB-2603 from 2016 to 2027

      • 1.3.2 USA Dermatomycoses Drug Market Size and Growth Rate of Clotrimazole from 2016 to 2027

      • 1.3.3 USA Dermatomycoses Drug Market Size and Growth Rate of Dapaconazole from 2016 to 2027

      • 1.3.4 USA Dermatomycoses Drug Market Size and Growth Rate of Others from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Dermatomycoses Drug Market Size and Growth Rate of Hospital from 2016 to 2027

      • 1.4.2 USA Dermatomycoses Drug Market Size and Growth Rate of Clinic from 2016 to 2027

      • 1.4.3 USA Dermatomycoses Drug Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Dermatomycoses Drug Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Dermatomycoses Drug Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Dermatomycoses Drug Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Dermatomycoses Drug Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Dermatomycoses Drug Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Dermatomycoses Drug by Major Types

      • 3.4.1 Market Size and Growth Rate of BB-2603

      • 3.4.2 Market Size and Growth Rate of Clotrimazole

      • 3.4.3 Market Size and Growth Rate of Dapaconazole

      • 3.4.4 Market Size and Growth Rate of Others

    4 Segmentation of Dermatomycoses Drug Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Dermatomycoses Drug by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Dermatomycoses Drug in Hospital

      • 4.4.2 Market Size and Growth Rate of Dermatomycoses Drug in Clinic

      • 4.4.3 Market Size and Growth Rate of Dermatomycoses Drug in Others

    5 Market Analysis by Regions

    • 5.1 USA Dermatomycoses Drug Production Analysis by Regions

    • 5.2 USA Dermatomycoses Drug Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Dermatomycoses Drug Landscape Analysis

    • 6.1 West USA Dermatomycoses Drug Landscape Analysis by Major Types

    • 6.2 West USA Dermatomycoses Drug Landscape Analysis by Major End-Users

    7 South USA Dermatomycoses Drug Landscape Analysis

    • 7.1 South USA Dermatomycoses Drug Landscape Analysis by Major Types

    • 7.2 South USA Dermatomycoses Drug Landscape Analysis by Major End-Users

    8 Middle West USA Dermatomycoses Drug Landscape Analysis

    • 8.1 Middle West USA Dermatomycoses Drug Landscape Analysis by Major Types

    • 8.2 Middle West USA Dermatomycoses Drug Landscape Analysis by Major End-Users

    9 Northeast USA Dermatomycoses Drug Landscape Analysis

    • 9.1 Northeast USA Dermatomycoses Drug Landscape Analysis by Major Types

    • 9.2 Northeast USA Dermatomycoses Drug Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Novan Inc

        • 10.1.1 Novan Inc Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Viamet Pharmaceuticals Inc

        • 10.2.1 Viamet Pharmaceuticals Inc Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Dermala Inc

        • 10.3.1 Dermala Inc Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Helix BioMedix Inc

        • 10.4.1 Helix BioMedix Inc Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Sol-Gel Technologies Ltd

        • 10.5.1 Sol-Gel Technologies Ltd Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 TGV-Laboratories

        • 10.6.1 TGV-Laboratories Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Blueberry Therapeutics Ltd

        • 10.7.1 Blueberry Therapeutics Ltd Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Vyome Biosciences Pvt Ltd

        • 10.8.1 Vyome Biosciences Pvt Ltd Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Anacor Pharmaceuticals Inc

        • 10.9.1 Anacor Pharmaceuticals Inc Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Daewoong Pharmaceutical Co Ltd

        • 10.10.1 Daewoong Pharmaceutical Co Ltd Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

      • 10.11 Biolab Farmaceutica Ltda

        • 10.11.1 Biolab Farmaceutica Ltda Company Profile and Recent Development

        • 10.11.2 Market Performance

        • 10.11.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Dermatomycoses Drug Market Size and Growth Rate of BB-2603 from 2016 to 2027

    • Figure USA Dermatomycoses Drug Market Size and Growth Rate of Clotrimazole from 2016 to 2027

    • Figure USA Dermatomycoses Drug Market Size and Growth Rate of Dapaconazole from 2016 to 2027

    • Figure USA Dermatomycoses Drug Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Dermatomycoses Drug Market Size and Growth Rate of Hospital from 2016 to 2027

    • Figure USA Dermatomycoses Drug Market Size and Growth Rate of Clinic from 2016 to 2027

    • Figure USA Dermatomycoses Drug Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Dermatomycoses Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Dermatomycoses Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Dermatomycoses Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Dermatomycoses Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Dermatomycoses Drug Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Dermatomycoses Drug

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Dermatomycoses Drug by Different Types from 2016 to 2027

    • Table Consumption Share of Dermatomycoses Drug by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of BB-2603

    • Figure Market Size and Growth Rate of Clotrimazole

    • Figure Market Size and Growth Rate of Dapaconazole

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Dermatomycoses Drug by Different End-Users from 2016 to 2027

    • Table Consumption Share of Dermatomycoses Drug by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Hospital

    • Figure Market Size and Growth Rate of Clinic

    • Figure Market Size and Growth Rate of Others

    • Table USA Dermatomycoses Drug Production by Regions

    • Table USA Dermatomycoses Drug Production Share by Regions

    • Figure USA Dermatomycoses Drug Production Share by Regions in 2016

    • Figure USA Dermatomycoses Drug Production Share by Regions in 2021

    • Figure USA Dermatomycoses Drug Production Share by Regions in 2027

    • Table USA Dermatomycoses Drug Consumption by Regions

    • Table USA Dermatomycoses Drug Consumption Share by Regions

    • Figure USA Dermatomycoses Drug Consumption Share by Regions in 2016

    • Figure USA Dermatomycoses Drug Consumption Share by Regions in 2021

    • Figure USA Dermatomycoses Drug Consumption Share by Regions in 2027

    • Table West USA Dermatomycoses Drug Consumption by Types from 2016 to 2027

    • Table West USA Dermatomycoses Drug Consumption Share by Types from 2016 to 2027

    • Figure West USA Dermatomycoses Drug Consumption Share by Types in 2016

    • Figure West USA Dermatomycoses Drug Consumption Share by Types in 2021

    • Figure West USA Dermatomycoses Drug Consumption Share by Types in 2027

    • Table West USA Dermatomycoses Drug Consumption by End-Users from 2016 to 2027

    • Table West USA Dermatomycoses Drug Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Dermatomycoses Drug Consumption Share by End-Users in 2016

    • Figure West USA Dermatomycoses Drug Consumption Share by End-Users in 2021

    • Figure West USA Dermatomycoses Drug Consumption Share by End-Users in 2027

    • Table South USA Dermatomycoses Drug Consumption by Types from 2016 to 2027

    • Table South USA Dermatomycoses Drug Consumption Share by Types from 2016 to 2027

    • Figure South USA Dermatomycoses Drug Consumption Share by Types in 2016

    • Figure South USA Dermatomycoses Drug Consumption Share by Types in 2021

    • Figure South USA Dermatomycoses Drug Consumption Share by Types in 2027

    • Table South USA Dermatomycoses Drug Consumption by End-Users from 2016 to 2027

    • Table South USA Dermatomycoses Drug Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Dermatomycoses Drug Consumption Share by End-Users in 2016

    • Figure South USA Dermatomycoses Drug Consumption Share by End-Users in 2021

    • Figure South USA Dermatomycoses Drug Consumption Share by End-Users in 2027

    • Table Middle West USA Dermatomycoses Drug Consumption by Types from 2016 to 2027

    • Table Middle West USA Dermatomycoses Drug Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Dermatomycoses Drug Consumption Share by Types in 2016

    • Figure Middle West USA Dermatomycoses Drug Consumption Share by Types in 2021

    • Figure Middle West USA Dermatomycoses Drug Consumption Share by Types in 2027

    • Table Middle West USA Dermatomycoses Drug Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Dermatomycoses Drug Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Dermatomycoses Drug Consumption Share by End-Users in 2016

    • Figure Middle West USA Dermatomycoses Drug Consumption Share by End-Users in 2021

    • Figure Middle West USA Dermatomycoses Drug Consumption Share by End-Users in 2027

    • Table Northeast USA Dermatomycoses Drug Consumption by Types from 2016 to 2027

    • Table Northeast USA Dermatomycoses Drug Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Dermatomycoses Drug Consumption Share by Types in 2016

    • Figure Northeast USA Dermatomycoses Drug Consumption Share by Types in 2021

    • Figure Northeast USA Dermatomycoses Drug Consumption Share by Types in 2027

    • Table Northeast USA Dermatomycoses Drug Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Dermatomycoses Drug Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Dermatomycoses Drug Consumption Share by End-Users in 2016

    • Figure Northeast USA Dermatomycoses Drug Consumption Share by End-Users in 2021

    • Figure Northeast USA Dermatomycoses Drug Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Novan Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novan Inc

    • Figure Sales and Growth Rate Analysis of Novan Inc

    • Figure Revenue and Market Share Analysis of Novan Inc

    • Table Product and Service Introduction of Novan Inc

    • Table Company Profile and Development Status of Viamet Pharmaceuticals Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Viamet Pharmaceuticals Inc

    • Figure Sales and Growth Rate Analysis of Viamet Pharmaceuticals Inc

    • Figure Revenue and Market Share Analysis of Viamet Pharmaceuticals Inc

    • Table Product and Service Introduction of Viamet Pharmaceuticals Inc

    • Table Company Profile and Development Status of Dermala Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dermala Inc

    • Figure Sales and Growth Rate Analysis of Dermala Inc

    • Figure Revenue and Market Share Analysis of Dermala Inc

    • Table Product and Service Introduction of Dermala Inc

    • Table Company Profile and Development Status of Helix BioMedix Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Helix BioMedix Inc

    • Figure Sales and Growth Rate Analysis of Helix BioMedix Inc

    • Figure Revenue and Market Share Analysis of Helix BioMedix Inc

    • Table Product and Service Introduction of Helix BioMedix Inc

    • Table Company Profile and Development Status of Sol-Gel Technologies Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sol-Gel Technologies Ltd

    • Figure Sales and Growth Rate Analysis of Sol-Gel Technologies Ltd

    • Figure Revenue and Market Share Analysis of Sol-Gel Technologies Ltd

    • Table Product and Service Introduction of Sol-Gel Technologies Ltd

    • Table Company Profile and Development Status of TGV-Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of TGV-Laboratories

    • Figure Sales and Growth Rate Analysis of TGV-Laboratories

    • Figure Revenue and Market Share Analysis of TGV-Laboratories

    • Table Product and Service Introduction of TGV-Laboratories

    • Table Company Profile and Development Status of Blueberry Therapeutics Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Blueberry Therapeutics Ltd

    • Figure Sales and Growth Rate Analysis of Blueberry Therapeutics Ltd

    • Figure Revenue and Market Share Analysis of Blueberry Therapeutics Ltd

    • Table Product and Service Introduction of Blueberry Therapeutics Ltd

    • Table Company Profile and Development Status of Vyome Biosciences Pvt Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vyome Biosciences Pvt Ltd

    • Figure Sales and Growth Rate Analysis of Vyome Biosciences Pvt Ltd

    • Figure Revenue and Market Share Analysis of Vyome Biosciences Pvt Ltd

    • Table Product and Service Introduction of Vyome Biosciences Pvt Ltd

    • Table Company Profile and Development Status of Anacor Pharmaceuticals Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Anacor Pharmaceuticals Inc

    • Figure Sales and Growth Rate Analysis of Anacor Pharmaceuticals Inc

    • Figure Revenue and Market Share Analysis of Anacor Pharmaceuticals Inc

    • Table Product and Service Introduction of Anacor Pharmaceuticals Inc

    • Table Company Profile and Development Status of Daewoong Pharmaceutical Co Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Daewoong Pharmaceutical Co Ltd

    • Figure Sales and Growth Rate Analysis of Daewoong Pharmaceutical Co Ltd

    • Figure Revenue and Market Share Analysis of Daewoong Pharmaceutical Co Ltd

    • Table Product and Service Introduction of Daewoong Pharmaceutical Co Ltd

    • Table Company Profile and Development Status of Biolab Farmaceutica Ltda

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biolab Farmaceutica Ltda

    • Figure Sales and Growth Rate Analysis of Biolab Farmaceutica Ltda

    • Figure Revenue and Market Share Analysis of Biolab Farmaceutica Ltda

    • Table Product and Service Introduction of Biolab Farmaceutica Ltda


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.